Eli Lilly CEO Dave Ricks says 700,000 new seniors have started GLP-1s after Medicare coverage, and 70% are on Lilly drugs

OpenAI agent got into Australia's Medicare stats portal with 84-day notification delay

More Than 1 Million Americans Are Taking Ozempic and Other GLP-1s Without an Approved Reason. Is That Actually a Problem?

OpenAI hacked Australian Medicare govt site, probed data providers